A-423,579

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
A-423,579
Stereo, Kekulé, skeletal formula of A-423,579 (({[(3R)-3-amino]}))
IUPAC ime
Identifikacija
CAS registarski broj 461045-17-0 DaY
PubChem[1][2] 11349657 (R)
22994515
ChemSpider[3] 9524593 (R) DaY, 13210784 DaY
ChEMBL[4] CHEMBL498228 DaY
Jmol-3D slike Slika 1
Slika 2
Svojstva
Molekulska formula C22H25F2N3O
Molarna masa 385.45 g mol−1

 DaY (šta je ovo?)   (verifikuj)

Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala

Infobox references

A-423,579 je histaminski antagonist koji je razvila kompanija Abot laboratorije. On je selektivan za H3 receptor, i ima stimulantno i anoreksično dejstvo u životinjskim studijama, te je potencijalno koristan tretman za gojaznost. A-423,579 ima poboljšane karakteristike u odnosu na druge ranije razvije lekove ove serije. On ima veću efikasnost i nižu toksičnost u istraživanjima na miševima, i trenutno je u kliničkom razvoju.[5][6]

Reference[uredi | uredi kod]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Hancock AA, Diehl MS, Faghih R, Bush EN, Krueger KM, Krishna G, Miller TR, Wilcox DM, Nguyen P, Pratt JK, Cowart MD, Esbenshade TA, Jacobson PB (September 2004). „In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists”. Basic Clin. Pharmacol. Toxicol. 95 (3): 144–52. DOI:10.1111/j.1742-7843.2004.950307.x. PMID 15447739. Arhivirano iz originala na datum 2012-07-31. Pristupljeno 2008-11-25. 
  6. Hancock AA, Diehl MS, Fey TA, Bush EN, Faghih R, Miller TR, Krueger KM, Pratt JK, Cowart MD, Dickinson RW, Shapiro R, Knourek-Segel VE, Droz BA, McDowell CA, Krishna G, Brune ME, Esbenshade TA, Jacobson PB (April 2005). „Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy”. Inflamm. Res. 54 Suppl 1: S27–9. DOI:10.1007/s00011-004-0412-z. PMID 15928821.